HIV

Dec. 17, 2024

A new fact sheet from CMS.

HIV

Twice-yearly lenacapavir for PrEP reduces HIV infections by 96%

LABline

Dec. 3, 2024

HIV

Policy expands access to life-saving organs for people with HIV

LABline

Nov. 27, 2024

HIV

Survey finds continued declines in HIV clinician workforce

LABline

Nov. 6, 2024

Transmission electron micrograph of HIV-1 virus particles.

HIV

Kidney transplantation between donors and recipients with HIV is safe

LABline

Oct. 18, 2024

HIV

Study finds telehealth effective for HIV patients

LABline

Oct. 9, 2024

HIV

CMS posts National Coverage Determination for PrEP to prevent HIV infection

LABline

Oct. 7, 2024

NCDs are posted on the CMS Medicare Coverage Center website and provide stakeholders with the Medicare coverage criteria for each technology, a summary of the evidence considered...

HIV

Proposed rule to expand access to life-saving organs for people with HIV

LABline

Sept. 16, 2024

Proposal to remove clinical research requirements for transplantation of kidneys and livers from donors with HIV.

HIV

CMS posts content on Medicare.gov in preparation of coverage transition from Part D to Part B of antiretroviral drugs to prevent HIV

LABline

Aug. 26, 2024

CMS update.

HIV

Administration announces more than $1.4 billion to provide lifesaving HIV medications and healthcare services to individuals with HIV with low incomes

LABline

Aug. 21, 2024

Funding will ensure that more than 290,000 people with HIV receive lifesaving HIV medication.

HIV

Only the urgent and accelerated delivery of HIV services will keep the promise of ending AIDS in children by 2030

LABline

July 25, 2024

Despite significant gains in many countries, critical gaps continue to undermine efforts to end AIDS in children.

HIV

Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy

LABline

July 24, 2024

NIH-sponsored study supports cabotegravir use throughout period of reproductive potential.

HIV

Exploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial

LABline

July 24, 2024

Findings add to body of evidence on cardiovascular risk factors for people with HIV.

HIV

Integrated DNA Technologies introduces new HIV panel

LABline

June 25, 2024

xGen HIV Amplicon Panel provides a single-tube, 2.5-hour workflow designed to enable detection down to 1,000 viral genome copies.

HIV

U.S. clinical trials begin for twice-yearly HIV prevention injection

LABline

June 5, 2024

Studies will focus on priority populations underrepresented in HIV clinical research.

HIV

Researchers a step closer to a cure for HIV

LABline

March 29, 2024

A new study involving University of Bristol researchers shows a virus-like particle (HLP) can effectively ‘shock and kill’ latent HIV reservoir in those living with chronic HIV...